Polaryx Therapeutics, Inc. (PLYX)
Nasdaq: PLYX · CIK 0002075320 · United States
Every official Polaryx Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PLYX filings
Polaryx Therapeutics, Inc. documents
- Polaryx Therapeutics, Inc. 10-K 2026PLYX 10-K 2026: annual report for fiscal 2026
- Polaryx Therapeutics, Inc. 10-K 2025PLYX 10-K 2025: annual report for fiscal 2025
- Polaryx Therapeutics, Inc. 10-K 2024PLYX 10-K 2024: annual report for fiscal 2024
- Polaryx Therapeutics, Inc. 10-K 2023PLYX 10-K 2023: annual report for fiscal 2023
- Polaryx Therapeutics, Inc. 10-K 2022PLYX 10-K 2022: annual report for fiscal 2022
- Polaryx Therapeutics, Inc. 10-Q 2026PLYX 10-Q 2026: quarterly report for fiscal 2026
- Polaryx Therapeutics, Inc. 10-Q 2025PLYX 10-Q 2025: quarterly report for fiscal 2025
- Polaryx Therapeutics, Inc. 10-Q 2024PLYX 10-Q 2024: quarterly report for fiscal 2024
- Polaryx Therapeutics, Inc. 10-Q 2023PLYX 10-Q 2023: quarterly report for fiscal 2023
- Polaryx Therapeutics, Inc. 10-Q 2022PLYX 10-Q 2022: quarterly report for fiscal 2022
- Polaryx Therapeutics, Inc. 8-K 2026PLYX 8-K 2026: current report for fiscal 2026
- Polaryx Therapeutics, Inc. 8-K 2025PLYX 8-K 2025: current report for fiscal 2025
- Polaryx Therapeutics, Inc. 8-K 2024PLYX 8-K 2024: current report for fiscal 2024
- Polaryx Therapeutics, Inc. 8-K 2023PLYX 8-K 2023: current report for fiscal 2023
- Polaryx Therapeutics, Inc. 8-K 2022PLYX 8-K 2022: current report for fiscal 2022
- Polaryx Therapeutics, Inc. DEF 14A 2026PLYX DEF 14A 2026: proxy statement for fiscal 2026
- Polaryx Therapeutics, Inc. DEF 14A 2025PLYX DEF 14A 2025: proxy statement for fiscal 2025
- Polaryx Therapeutics, Inc. DEF 14A 2024PLYX DEF 14A 2024: proxy statement for fiscal 2024
- Polaryx Therapeutics, Inc. DEF 14A 2023PLYX DEF 14A 2023: proxy statement for fiscal 2023
- Polaryx Therapeutics, Inc. DEF 14A 2022PLYX DEF 14A 2022: proxy statement for fiscal 2022
- Polaryx Therapeutics, Inc. Form 4 2026PLYX Form 4 2026: insider trading filing for fiscal 2026
- Polaryx Therapeutics, Inc. Form 4 2025PLYX Form 4 2025: insider trading filing for fiscal 2025
- Polaryx Therapeutics, Inc. Form 4 2024PLYX Form 4 2024: insider trading filing for fiscal 2024
- Polaryx Therapeutics, Inc. Form 4 2023PLYX Form 4 2023: insider trading filing for fiscal 2023
- Polaryx Therapeutics, Inc. Form 4 2022PLYX Form 4 2022: insider trading filing for fiscal 2022
- Polaryx Therapeutics, Inc. S-1 2026PLYX S-1 2026: registration statement for fiscal 2026
- Polaryx Therapeutics, Inc. S-1 2025PLYX S-1 2025: registration statement for fiscal 2025
- Polaryx Therapeutics, Inc. S-1 2024PLYX S-1 2024: registration statement for fiscal 2024
- Polaryx Therapeutics, Inc. S-1 2023PLYX S-1 2023: registration statement for fiscal 2023
- Polaryx Therapeutics, Inc. S-1 2022PLYX S-1 2022: registration statement for fiscal 2022
- Polaryx Therapeutics, Inc. 13F 2026PLYX 13F 2026: institutional holdings for fiscal 2026
- Polaryx Therapeutics, Inc. 13F 2025PLYX 13F 2025: institutional holdings for fiscal 2025
- Polaryx Therapeutics, Inc. 13F 2024PLYX 13F 2024: institutional holdings for fiscal 2024
- Polaryx Therapeutics, Inc. 13F 2023PLYX 13F 2023: institutional holdings for fiscal 2023
- Polaryx Therapeutics, Inc. 13F 2022PLYX 13F 2022: institutional holdings for fiscal 2022
More companies